Pharma major Lupin Limited (Lupin) announced that it has received approval for its Sildenafil Tablets USP, 25 mg, 50 mg, and 100 mg from the United States Food and Drug Administration (FDA) to market a generic version of Pfizer Inc's Viagra Tablets, 25 mg, 50 mg, and 100 mg.
Lupin's Sildenafil Tablets USP, 25 mg, 50 mg, and 100 mg, is the generic version Pfizer Inc's Viagra Tablets, 25 mg, 50 mg, and 100 mg. Sildenafil Tablets are a phosphodiesterase-5 (PDE5) inhibitor indicated for the treatm ent of erectile dysfunction (ED).
Sildenafil Tablets USP, 25 mg, 50 mg, and 100 mg had an annual sales of approximately USD 611 million in the US (IQVIA MAT December 2018).
Shares of LUPIN LTD. was last trading in BSE at Rs.743.55 as compared to the previous close of Rs. 752.55. The total number of shares traded during the day was 70868 in over 2035 trades.
The stock hit an intraday high of Rs. 757.15 and intraday low of 741. The net turnover during the day was Rs. 53025428.